COVID-19: Successful mass production of powder vaccine: “Morimoto Pharmaceutical”
-Developed by a pharmaceutical venture in Osaka-
“Morimoto medicine”:
We have succeeded in developing a technology for powdering the vaccine solution and mass-producing it.
Conventional method:
Only about 5 times of powdered vaccine could be made in one process.
This method:
Morimoto Pharmaceutical has developed a technology that can manufacture 25 doses, which is five times as much.
Morimoto medicine
President Shuji Morimoto:
Because the liquid is simply dried
The weight of the liquid part is gone,
It is also lighter in weight.
With this, you can prepare for 1000 times.
Logistics, storage and handling are extremely compact and easy.
A large amount of vaccine can be stored and transferred at room temperature,
Vaccine management is easier,
Vaccine disposal is reduced.
Practical use during next year:
A production line will be set up at the factory for practical use within the next fiscal year.
It is said that it will prepare a system to supply 20 million bottles a year.
Yomiuri TV News